Handok Pharmaceuticals Co., Ltd. · 66-41 · KOREA (THE REPUBLIC OF)
For Handok Pharmaceuticals Co., Ltd., import alert is 66-41; country is KOREA (THE REPUBLIC OF); import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; product is Festal Plus Tablets | Festal Plus Tablets; product code is 64 E - - 01 Cellulase (Enzyme) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 08/05/2019; address is unknown , Chungchongbuk, KOREA (THE REPUBLIC OF), verified against its source on 2026-10-01.
- Firm
- Handok Pharmaceuticals Co., Ltd. verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- KOREA (THE REPUBLIC OF) verified
- Address
- unknown , Chungchongbuk, KOREA (THE REPUBLIC OF) verified
- Date published
- 08/05/2019 verified
- Product code
- 64 E - - 01 Cellulase (Enzyme) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- Festal Plus Tablets | Festal Plus Tablets each item verified
- FDA notes
- The product appears to be an unapproved new drug as the product contains the active ingredient pancreatin and the product label notes the product's intended use as a digestive aid by listing (not an all-inclusive list); '...Uses; Digestion...'. | The product appears to be an unapproved new drug as the product contains the active ingredient pancreatin and the product label notes the product's intended use as a digestive aid by listing (not an all-inclusive list); '...Uses; Digestion...'. each item verified
What the source says
Handok Pharmaceuticals Co., Ltd. Date Published : 08/05/2019 unknown , Chungchongbuk, KOREA (THE REPUBLIC OF)
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
64 E - - 01 Cellulase (Enzyme) Date Published: 08/05/2019 Desc: Festal Plus Tablets Notes: The product appears to be an unapproved new drug as the product contains the active ingredient pancreatin and the product label notes the product's intended use as a digestive aid by listing (not an all-inclusive list); '...Uses; Digestion...'. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 08/05/2019 Desc: Festal Plus Tablets Notes: The product appears to be an unapproved new drug as the product contains the active ingredient pancreatin and the product label notes the product's intended use as a digestive aid by listing (not an all-inclusive list); '...Uses; Digestion...'.
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.